
VolitionRx Limited VNRX
$ 0.2
-3.79%
Quarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited EV/EBITDA Ratio 2011-2026 | VNRX
Annual EV/EBITDA Ratio VolitionRx Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.45 | - | -11.2 | -4.04 | -6.02 | -7.16 | -6.29 | -11.3 | -6.37 | 339 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 339 | -11.3 | 31.4 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.83 | -4.39 % | $ 91.8 K | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
27.4 | $ 116.37 | -1.49 % | $ 35.4 B | ||
|
Celcuity
CELC
|
-2.38 | $ 105.97 | -2.15 % | $ 4.18 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 173.71 | -2.76 % | $ 8.61 B | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 27.4 | -2.11 % | $ 761 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 15.93 | 1.14 % | $ 2.07 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 13.83 | -2.61 % | $ 418 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.11 | -3.07 % | $ 1.41 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 205.94 | -2.06 % | $ 22.9 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 202.02 | -1.88 % | $ 144 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 103.3 | -0.05 % | $ 19.5 B | ||
|
Bioventus
BVS
|
26.4 | $ 8.64 | -1.48 % | $ 541 M | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 10.5 | -2.33 % | $ 298 M | ||
|
DexCom
DXCM
|
39.5 | $ 73.05 | -1.0 % | $ 28.5 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 24.2 | -3.82 % | $ 258 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 18.27 | -2.53 % | $ 974 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 105.46 | -2.6 % | $ 8.7 B | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 642.76 | 0.95 % | $ 51.7 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Illumina
ILMN
|
70.5 | $ 128.99 | -2.93 % | $ 20.5 B | ||
|
Guardant Health
GH
|
-28.8 | $ 90.81 | -1.54 % | $ 11.4 B | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 171.78 | -1.43 % | $ 29.5 B | ||
|
Brainsway Ltd.
BWAY
|
-43.6 | $ 22.69 | -4.22 % | $ 99.4 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 280.06 | -2.17 % | $ 23.3 B | ||
|
Co-Diagnostics
CODX
|
3.62 | - | - | $ 79.8 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 77.65 | 1.77 % | $ 5.24 B | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 309.79 | -1.0 % | $ 27 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.93 | -1.6 % | $ 457 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 9.13 | -3.89 % | $ 1.17 B | ||
|
Natera
NTRA
|
-19.5 | $ 200.13 | 0.2 % | $ 19.7 B | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.51 | -7.1 % | $ 453 M | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 10.97 | -1.61 % | $ 2.38 B | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Precipio
PRPO
|
-1.8 | $ 24.5 | -0.73 % | $ 31.8 M |